Biotech Stocks

Some good Biotech stocks to buy in a down market:

Vertex Pharmaceuticals: The company dominates the cystic fibrosis (CF) market with its four FDA-approved drugs. Sales for a couple of these drugs -- Orkambi and Symdeko -- are sure to increase significantly over the next few years thanks to reimbursement deals recently signed in important European markets.

Lexicon Pharmaceuticals: The company develops and markets drugs for the treatment of diabetes, neuropathic pain, and cancer-related intestinal issues. On December 20, the company announced promising results in the Phase 3 trial of Sotagliflozin, a compound for the treatment of type 2 diabetes.

bluebird bio: Launched in Germany Zynteglo (also known as LentiGlobin), a gene therapy that targets the treatment of transfusion-dependent beta-thalassemia (TDT), following securing European approval. Zynteglo isn't approved in the U.S. yet, but Bluebird expects to file for FDA approval in the first half of this year.

---

anonymous Investing March 13, 2020 at 12:22 pm 0 0